51-38-7 Usage
Uses
Used in Sunscreen Formulations:
Butyl 4-hydroxy-3,5-diiodobenzoate is used as a UV absorber in sunscreen formulations for its capacity to absorb ultraviolet radiation, thereby preventing skin damage caused by excessive sun exposure. Its inclusion in sunscreens helps in reducing the risk of skin cancers and premature aging.
Used in Personal Care Products:
butyl 4-hydroxy-3,5-diiodobenzoate is also utilized in the production of various personal care products such as lotions, moisturizers, and other skincare formulations. Its role in these products is to provide protection against UV radiation, ensuring that the skin remains healthy and shielded from harmful environmental factors.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, butyl 4-hydroxy-3,5-diiodobenzoate may be used in the development of topical medications designed to protect the skin from UV damage or as a component in formulations targeting specific skin conditions that may be exacerbated by sun exposure.
Safety Considerations:
It is important to handle butyl 4-hydroxy-3,5-diiodobenzoate with care, as it can be irritating to the skin, eyes, and respiratory system. It should only be used in well-ventilated areas, and appropriate protective equipment should be worn to minimize potential health risks during its application in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 51-38-7 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 5 and 1 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 51-38:
(4*5)+(3*1)+(2*3)+(1*8)=37
37 % 10 = 7
So 51-38-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H12I2O3/c1-2-3-4-16-11(15)7-5-8(12)10(14)9(13)6-7/h5-6,14H,2-4H2,1H3
51-38-7Relevant academic research and scientific papers
Disconnecting the Estrogen Receptor Binding Properties and Antimicrobial Properties of Parabens through 3,5-Substitution
Bergquist, Bridget L.,Jefferson, Kaelyn G.,Kintz, Hailey N.,Barber, Amorette E.,Yeagley, Andrew A.
supporting information, p. 51 - 55 (2018/05/04)
Commercially utilized parabens are employed for their antimicrobial properties, but a weak binding to the estrogen receptor alpha (ERα) may lead to breast cancer in some applications. Modification of the paraben scaffold should allow for a disconnection of these observed properties. Toward this goal, various 3,5-substituted parabens were synthesized and assessed for antimicrobial properties against S. aureus as well as competitive binding to the ERα. The minimum inhibitory concentration assay confirmed retention of antimicrobial activity in many of these derivatives, while all compounds exhibited decreased xenoestrogen activity as determined by a combination of competitive enzyme linked immunosorbent assay (ELISA), proliferation, and estrogen receptor binding assay. Thus, these changes to the paraben scaffold have led to a multitude of paraben derivatives with antimicrobial properties up to 16 times more active than the parent paraben and that are devoid or significantly diminished of potential breast cancer causing properties.
